Genprex

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genprex and other ETFs, options, and stocks.

About GNPX

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer.

CEO

J. Rodney Varner

CEOJ. Rodney Varner

Employees

Employees26

Headquarters

Austin, Texas

HeadquartersAustin, Texas

Founded

2009

Founded2009

Employees

Employees26

GNPX Key Statistics

Market cap

5.08M

Market cap5.08M

Price-Earnings ratio

-0.11

Price-Earnings ratio-0.11

Dividend yield

—

Dividend yield—

Average volume

17.29K

Average volume17.29K

High today

—

High today—

Low today

—

Low today—

Open price

$2.39

Open price$2.39

Volume

0.00

Volume0.00

52 Week high

$42.40

52 Week high$42.40

52 Week low

$2.09

52 Week low$2.09

GNPX News

Yahoo Finance 5d

Genprex to Present and Participate at Upcoming May Investor and Industry Conferences - Yahoo Finance

AUSTIN, Texas, May. 1, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developi...